A European study in 1359 breast cancer cases and 2389 matched controls found that carriers of the ghrelin rs171407-G allele had a significantly increased breast cancer risk (OR: 1.2, 95% CI: 1.0–1.4; P=0.02) (Dossus et al. 2008). Here, GHRL is linked to breast carcinoma.